Brind.
  1. Congress considered proposals to strengthen FDA authority regarding medical device regulation and minimum standards.
  2. Policymakers are considering ways to influence the drug market, including potential changes to patent rights and the FDA approval process.

Congress and the Senate are considering legislation affecting FDA submissions and drug patent rights.

2 reports, 2 independent Updated 20:15
Still developing
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Congress and the Senate are considering legislation affecting FDA submissions and drug patent rights.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Senate advances FDA funding bill to the House1 source
  2. Congress and Senate report on bills concerning FDA submissions and drug patents.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped